Park Seongjin, Lee Hyo Jin, Song Sung-Hee, Woo KyungChang, Kim Jiwon, Kim Juwon, Kim Ju Youn, Park Seung-Jung, On Young Keun, Park Kyoung-Min
Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
Division of Cardiology, Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon 51353, Republic of Korea.
J Clin Med. 2025 Jun 15;14(12):4257. doi: 10.3390/jcm14124257.
Most previous studies using artificial intelligence (AI) to detect left ventricular systolic dysfunction (LVSD) from electrocardiograms (ECGs) relied on data obtained near the time of echocardiography or included patients with known cardiac disease, limiting their specificity for screening. We aimed to evaluate whether AI models could predict future LVSD from ECGs interpreted as normal and recorded one to two years before echocardiography. We retrospectively analyzed 24,203 sinus rhythm ECGs from 11,131 patients. Two convolutional neural network models (DenseNet-121 and ResNet-101) were trained (70%), validated (10%), and tested (20%) to predict LVSD (defined as ejection fraction ≤50%). Survival analysis was performed using Kaplan-Meier curves and the log-rank test. Of the total population, 2734 patients had LVSD and 8397 had preserved EF. DenseNet-121 and ResNet-101 demonstrated excellent discrimination for LVSD with AUROCs of 0.930 and 0.925, accuracies of 0.887 and 0.860, sensitivities of 0.821 and 0.856, and specificities of 0.908 and 0.861, respectively. In the test set, patients predicted to have LVSD showed a significantly higher risk of echocardiographic LVSD (hazard ratio 9.89, 95% CI 8.20-11.92, = 0.005) and lower 24-month survival (log-rank < 0.001). AI-enabled ECG models predicted future LVSD from clinically normal ECGs recorded up to two years prior to imaging. These findings suggest a potential role for AI-ECG in the early detection of subclinical LVSD and improved risk stratification in asymptomatic individuals.
以往大多数利用人工智能(AI)从心电图(ECG)检测左心室收缩功能障碍(LVSD)的研究,依赖于超声心动图检查时或其前后获取的数据,或纳入了已知心脏病患者,这限制了其筛查的特异性。我们旨在评估AI模型能否根据在超声心动图检查前一到两年记录的、解读为正常的ECG预测未来的LVSD。我们对11,131例患者的24,203份窦性心律ECG进行了回顾性分析。训练(70%)、验证(10%)和测试(20%)了两个卷积神经网络模型(DenseNet-121和ResNet-101)以预测LVSD(定义为射血分数≤50%)。使用Kaplan-Meier曲线和对数秩检验进行生存分析。在总人群中,2734例患者有LVSD,8397例患者射血分数保留。DenseNet-121和ResNet-101对LVSD表现出出色的辨别能力,曲线下面积(AUROC)分别为(0.930)和(0.925),准确率分别为(0.887)和(0.860),敏感性分别为(0.821)和(0.856),特异性分别为(0.908)和(0.861)。在测试集中,预测有LVSD的患者出现超声心动图LVSD的风险显著更高(风险比9.89,95%可信区间8.20 - 11.92,(P = 0.005)),24个月生存率更低(对数秩检验(P < 0.001))。基于AI的ECG模型能根据成像前长达两年记录的临床正常ECG预测未来的LVSD。这些发现表明AI-ECG在亚临床LVSD的早期检测及无症状个体风险分层改善方面具有潜在作用。